Patent Assignment
Reel/Frame 030766/0522
Assignment of Assignor's Interest
Recorded: 2013-07-10
Pages: 7
Assignors
ECKELMAN, BRENDAN
Executed: 2013-06-28
TIMMER, JOHN
Executed: 2013-06-28
RAZAI, AMIR
Executed: 2013-06-28
DEVERAUX, QUINN
Executed: 2013-06-28
JONES, KYLE
Executed: 2013-06-28
NGUY, PETER L.
Executed: 2013-06-28
Assignee
INHIBRX LLC
11099 N. TORREY PINES ROAD, SUITE 130, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
CD47 Antibodies and Methods of Use Thereof
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Oct 25, 2019
From: INHIBRX, LLC
To: INHIBRX, LP
Reel/Frame 050832/0610 →
Merger
Oct 25, 2019
From: INHIBRX, LP
To: INHIBRX, INC.
Reel/Frame 050890/0760 →
Intellectual Property Security Agreement
Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Release of Security Interest
Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067680/0770 →
Security Interest
Jan 14, 2025
From: INHIBRX BIOSCIENCES, INC.
To: OXFORD FINANCE LLC; OXFORD FINANCE LLC
Reel/Frame 069894/0045 →